家家悦：12月9日召开董事会会议

Group 1 - Company Jiajiayue (SH 603708) held its sixth meeting of the fifth board of directors on December 9, 2025, to review proposals including the postponement of certain fundraising investment projects [1] - For the first half of 2025, Jiajiayue's revenue composition was as follows: commercial business accounted for 92.63%, other businesses 6.85%, and industrial business 0.52% [1] - As of the report date, Jiajiayue's market capitalization was 7.6 billion yuan [1] Group 2 - The article highlights a significant issue in the pharmaceutical industry regarding the abuse of pregabalin, marking the first reported case of addiction in China [1] - It points out vulnerabilities in online platforms that allow the purchase of medications without medical records, raising concerns about regulatory oversight [1] - The classification of pregabalin and the need for scientific evaluation regarding its regulation are emphasized [1]